Immune-related Adverse Event of Colitis due to Pembrolizumab Treatment

Author:

Yamamoto Toshiki1,Horii Toshiki1,Ikehara Hisatomo1,Suzuki Sho1,Kusano Chika2,Tang Xiaoyan3

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Nihon University Hospital, Chiyoda, Tokyo 101–8309, Japan

2. Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252–0374, Japan

3. Division of Oncologic Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine, Nihon University Hospital, Chiyoda, Tokyo 101–8309, Japan

Publisher

Nihon University School of Dentistry at Matsudo Research Institute of Oral Science

Subject

General Medicine

Reference10 articles.

1. 1. Das S, Johnson DB: Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibi tors. J Immunother Cancer, 7: 306, 2019.

2. 2. Baxi S, Yang A, Gennarelli RL, Khan N, Wang Z, Boyce L, Korenstein D: Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis. BMJ, 360: k793, 2018.

3. 3. Thompson JA, Schneider BJ, Brahmer J, Andrews S, Armand P, Bhatia S, Budde LE, Costa L, Davies M, Dunnington D, Ernstoff MS, Frigault M, Kaffenberger BH, Lunning M, McGettigan S, McPherson J, Mohindra NA, Naidoo J, Olszanski AJ, Oluwole O, Patel SP, Pennell N, Reddy S, Ryder M, Santomasso B, Shofer S, Sosman JA, Wang Y, Weight RM, Johnson-Chilla A,

4. Zuccarino-Catania G, Engh A: NCCN guidelines insights: management of immunotherapy-related toxicities, version 1. 2020. J Natl Compr Canc Netw, 18: 230–241, 2020.

5. 4. Kleiner DE, Berman D: Pathological changes in ipilimumab-related hepatitis in patients with metastatic melanoma. Dig Dis Sci, 57: 2233–2240, 2012.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3